Uma Jagadish Damle

Uma Damle practices at NYU Langone - Tisch Hospital in New York, New York.

Uma Damle's NPI, 1720440878, was assigned on March 27, 2016. Uma Damle holds Pennsylvania license MT211167.

Uma Damle's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Uma Damle's primary practice is NYU Langone - Tisch Hospital in New York, New York. Uma Damle is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Uma Damle to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Uma Damle practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Uma Damle's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Uma Damle is licensed in Pennsylvania.

CMS data shows 368 Medicare services from Uma Damle across 5 procedure codes in 2024, for 259 Medicare patients. Medicare paid $36,483 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 259 Medicare patients who saw Uma Damle in 2024. The largest group is 75 to 84, with 92 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Uma Damle's median patient age at 45, with 56% women.

In 2024, Uma Damle wrote 162 Medicare Part D claims for 118 patients. 93% of them were for generic drugs. CMS names the drug for 59 of them, across 3 drugs with 11 or more claims each, at $227 in total drug cost. In 2023, CMS named 79 claims across 6 drugs.

Uma Damle accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 12 general payments to Uma Damle from 5 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Beckman Coulter, Inc. paid the most, $160.